Literature DB >> 25939424

Structural and Functional Impact of Parkinson Disease-Associated Mutations in the E3 Ubiquitin Ligase Parkin.

Fabienne C Fiesel1, Thomas R Caulfield1, Elisabeth L Moussaud-Lamodière1, Kotaro Ogaki1, Daniel F A R Dourado2, Samuel C Flores2, Owen A Ross1,3, Wolfdieter Springer1,3.   

Abstract

Mutations in the PARKIN/PARK2 gene that result in loss-of-function of the encoded, neuroprotective E3 ubiquitin ligase Parkin cause recessive, familial early-onset Parkinson disease. As an increasing number of rare Parkin sequence variants with unclear pathogenicity are identified, structure-function analyses will be critical to determine their disease relevance. Depending on the specific amino acids affected, several distinct pathomechanisms can result in loss of Parkin function. These include disruption of overall Parkin folding, decreased solubility, and protein aggregation. However pathogenic effects can also result from misregulation of Parkin autoinhibition and of its enzymatic functions. In addition, interference of binding to coenzymes, substrates, and adaptor proteins can affect its catalytic activity too. Herein, we have performed a comprehensive structural and functional analysis of 21 PARK2 missense mutations distributed across the individual protein domains. Using this combined approach, we were able to pinpoint some of the pathogenic mechanisms of individual sequence variants. Similar analyses will be critical in gaining a complete understanding of the complex regulations and enzymatic functions of Parkin. These studies will not only highlight the important residues, but will also help to develop novel therapeutics aimed at activating and preserving an active, neuroprotective form of Parkin.
© 2015 WILEY PERIODICALS, INC.

Entities:  

Keywords:  EOPD; PARK2; PINK1; Parkinson; mitophagy; molecular dynamics

Mesh:

Substances:

Year:  2015        PMID: 25939424      PMCID: PMC4514554          DOI: 10.1002/humu.22808

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  56 in total

1.  Predicting changes in the stability of proteins and protein complexes: a study of more than 1000 mutations.

Authors:  Raphael Guerois; Jens Erik Nielsen; Luis Serrano
Journal:  J Mol Biol       Date:  2002-07-05       Impact factor: 5.469

2.  Diverse effects of pathogenic mutations of Parkin that catalyze multiple monoubiquitylation in vitro.

Authors:  Noriyuki Matsuda; Toshiaki Kitami; Toshiaki Suzuki; Yoshikuni Mizuno; Nobutaka Hattori; Keiji Tanaka
Journal:  J Biol Chem       Date:  2005-12-08       Impact factor: 5.157

3.  Parkin-catalyzed ubiquitin-ester transfer is triggered by PINK1-dependent phosphorylation.

Authors:  Masahiro Iguchi; Yuki Kujuro; Kei Okatsu; Fumika Koyano; Hidetaka Kosako; Mayumi Kimura; Norihiro Suzuki; Shinichiro Uchiyama; Keiji Tanaka; Noriyuki Matsuda
Journal:  J Biol Chem       Date:  2013-06-10       Impact factor: 5.157

Review 4.  What genetics tells us about the causes and mechanisms of Parkinson's disease.

Authors:  Olga Corti; Suzanne Lesage; Alexis Brice
Journal:  Physiol Rev       Date:  2011-10       Impact factor: 37.312

5.  Parkin mitochondrial translocation is achieved through a novel catalytic activity coupled mechanism.

Authors:  Xinde Zheng; Tony Hunter
Journal:  Cell Res       Date:  2013-05-14       Impact factor: 25.617

6.  Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin.

Authors:  Sathya R Sriram; Xiaojie Li; Han Seok Ko; Kenny K K Chung; Esther Wong; Kah Leong Lim; Valina L Dawson; Ted M Dawson
Journal:  Hum Mol Genet       Date:  2005-07-27       Impact factor: 6.150

7.  Ubiquitin is phosphorylated by PINK1 to activate parkin.

Authors:  Fumika Koyano; Kei Okatsu; Hidetaka Kosako; Yasushi Tamura; Etsu Go; Mayumi Kimura; Yoko Kimura; Hikaru Tsuchiya; Hidehito Yoshihara; Takatsugu Hirokawa; Toshiya Endo; Edward A Fon; Jean-François Trempe; Yasushi Saeki; Keiji Tanaka; Noriyuki Matsuda
Journal:  Nature       Date:  2014-06-04       Impact factor: 49.962

8.  Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase.

Authors:  H Shimura; N Hattori; S i Kubo; Y Mizuno; S Asakawa; S Minoshima; N Shimizu; K Iwai; T Chiba; K Tanaka; T Suzuki
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

9.  Examinations of tRNA Range of Motion Using Simulations of Cryo-EM Microscopy and X-Ray Data.

Authors:  Thomas R Caulfield; Batsal Devkota; Geoffrey C Rollins
Journal:  J Biophys       Date:  2011-03-28
View more
  38 in total

1.  Dynamics of PARKIN-Dependent Mitochondrial Ubiquitylation in Induced Neurons and Model Systems Revealed by Digital Snapshot Proteomics.

Authors:  Alban Ordureau; Joao A Paulo; Wei Zhang; Tim Ahfeldt; Jiuchun Zhang; Erin F Cohn; Zhonggang Hou; Jin-Mi Heo; Lee L Rubin; Sachdev S Sidhu; Steven P Gygi; J Wade Harper
Journal:  Mol Cell       Date:  2018-04-12       Impact factor: 17.970

Review 2.  Parkin and PINK1 functions in oxidative stress and neurodegeneration.

Authors:  Sandeep K Barodia; Rose B Creed; Matthew S Goldberg
Journal:  Brain Res Bull       Date:  2016-12-23       Impact factor: 4.077

3.  UbMES and UbFluor: Novel probes for ring-between-ring (RBR) E3 ubiquitin ligase PARKIN.

Authors:  Sungjin Park; Peter K Foote; David T Krist; Sarah E Rice; Alexander V Statsyuk
Journal:  J Biol Chem       Date:  2017-07-14       Impact factor: 5.157

4.  Reply: Heterozygous PINK1 p.G411S in rapid eye movement sleep behaviour disorder.

Authors:  Andreas Puschmann; Fabienne C Fiesel; Thomas R Caulfield; Roman Hudec; Maya Ando; Dominika Truban; Xu Hou; Kotaro Ogaki; Michael G Heckman; Elle D James; Maria Swanberg; Itzia Jimenez-Ferrer; Oskar Hansson; Grzegorz Opala; Joanna Siuda; Magdalena Boczarska-Jedynak; Andrzej Friedman; Dariusz Koziorowski; Monika Rudzinska-Bar; Jan O Aasly; Timothy Lynch; George D Mellick; Megha Mohan; Peter A Silburn; Yanosh Sanotsky; Carles Vilariño-Güell; Matthew J Farrer; Li Chen; Valina L Dawson; Ted M Dawson; Zbigniew K Wszolek; Owen A Ross; Wolfdieter Springer
Journal:  Brain       Date:  2017-06-01       Impact factor: 13.501

5.  Monitoring PARKIN RBR Ubiquitin Ligase Activation States with UbFluor.

Authors:  Peter K Foote; Alexander V Statsyuk
Journal:  Curr Protoc Chem Biol       Date:  2018-07-31

Review 6.  Building and decoding ubiquitin chains for mitophagy.

Authors:  J Wade Harper; Alban Ordureau; Jin-Mi Heo
Journal:  Nat Rev Mol Cell Biol       Date:  2018-01-23       Impact factor: 94.444

7.  The landscape of Parkin variants reveals pathogenic mechanisms and therapeutic targets in Parkinson's disease.

Authors:  Wei Yi; Emma J MacDougall; Matthew Y Tang; Andrea I Krahn; Ziv Gan-Or; Jean-François Trempe; Edward A Fon
Journal:  Hum Mol Genet       Date:  2019-09-01       Impact factor: 6.150

Review 8.  Autophagy in Parkinson's Disease.

Authors:  Xu Hou; Jens O Watzlawik; Fabienne C Fiesel; Wolfdieter Springer
Journal:  J Mol Biol       Date:  2020-02-13       Impact factor: 5.469

Review 9.  Expanding the ubiquitin code through post-translational modification.

Authors:  Lina Herhaus; Ivan Dikic
Journal:  EMBO Rep       Date:  2015-08-12       Impact factor: 8.807

Review 10.  A Biochemical and Structural Understanding of TOM Complex Interactions and Implications for Human Health and Disease.

Authors:  Ashley S Pitt; Susan K Buchanan
Journal:  Cells       Date:  2021-05-11       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.